United States. Securities and Exchange Commission
Xoma Corp. has made a submission to the U.S. Securities and Exchange Commission (SEC) regarding its ownership in Pharmaceutical Preparations, according to a recent filing. The company, which has its headquarters located at 2910 SEVENTH ST, BERKELEY CA 94710, has a SIC code of 2834 and is registered under
United States. Securities and Exchange Commission
Applied Optoelectronics, Inc. (AOI) made a significant filing with the U.S. Securities and Exchange Commission (SEC) on March 31, 2015. This filing, reported using Form 8-K, revealed information about the company's material events and corporate changes. As a leading manufacturer of optoelectronic products, AOI's filing
United States. Securities and Exchange Commission
Ipg Photonics Corp. filed a Form 8-K report with the U.S. Securities and Exchange Commission on March 26, 2015, revealing the company's intention to report material events or corporate changes previously unreported. This filing, SIC code 3674, Semiconductors and Related Devices, provides more current information on specified
United States. Securities and Exchange Commission
Regen Biopharma Inc., a publicly traded company in the pharmaceutical preparations industry, filed a significant document with the U.S. Securities and Exchange Commission (SEC) on March 24, 2015. The filing, designated as Form 8-K, reported material events and corporate changes that were not previously disclosed to investors or security
United States. Securities and Exchange Commission
Xoma Corp. has made a new filing with the Securities and Exchange Commission (SEC) detailing a significant event in the pharmaceutical industry. According to the filing, Xoma Corp. has engaged in a notable transaction within the company, which is outlined in the document. This filing provides valuable insight into the
United States. Securities and Exchange Commission
Zimmer Holdings Inc. has conditionally cleared its proposed acquisition of Biomet, Inc. after the European Commission ("EC") gave its conditional approval. The EC's clearance is contingent upon Zimmer divesting certain assets as part of a remedy package previously submitted. This development follows clearance from the Japan
United States. Securities and Exchange Commission
Stereotaxis, Inc., a Delaware-based company, has entered into a Tenth Loan Modification Agreement with Silicon Valley Bank to extend the maturity of its revolving credit facility from March 31, 2015, to March 31, 2018. This modification, announced on March 30, 2015, also revises the financial covenants under the agreement to
United States. Securities and Exchange Commission
The U.S. Securities and Exchange Commission (SEC) has denied efforts by Gilead Sciences and Vertex Pharmaceuticals to block shareholder resolutions asking for greater transparency around the management and mitigation of business risks from rapidly increasing U.S. drug prices. The shareholder resolutions, filed by the UAW Retiree Medical Benefits
United States. Securities and Exchange Commission
Vertex Pharmaceuticals Inc., a leading developer of innovative medicines for the treatment of serious diseases, recently filed a Form 4 with the U.S. Securities and Exchange Commission (SEC) on March 6, 2015. The filing reports a director-officer's ownership and transactions of equity securities. As a publicly-traded company,
United States. Securities and Exchange Commission
Vertex Pharmaceuticals Inc., a leading developer of innovative medicines for the treatment of serious diseases, recently filed a Form 4 document with the U.S. Securities and Exchange Commission (SEC). The filing, which was received on February 27, 2015, provides detailed information about the company's equity securities and
United States. Securities and Exchange Commission
Xoma Corp., a pharmaceutical preparations company based in California, has filed a SEC Form 4 filing with the U.S. Securities and Exchange Commission (SEC). The filing, which was posted on March 2, 2015, contains information on the company's ownership and transactions involving its equity securities. The SEC
United States. Securities and Exchange Commission
EverBank Financial Corp, through its subsidiary EverBank, has announced a secondary public offering of 2,910,801 shares of its common stock by existing stockholders Sageview Partners L.P. and Teachers Insurance and Annuity Association of America. This underwritten offering, led by Barclays Capital Inc., will not result in any
